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Background: Rheumatoid arthritis (RA) is associated with a higher risk for coronary artery disease (CAD). Traditional risk factors are 
limited in their predictive accuracy for CAD. Our objective was to study the association between RA specific factors and CAD in patients 
with RA.
methods: 84 patients with chronic rheumatoid arthritis followed at a tertiary care facility for a median duration of 5.2 years. Demographic, 
risk factor, invasive angiography and revascularization data was recorded. Association between traditional risk factors and markers of RA 
disease activity and development of angiographically significant CAD was computed.
results: Mean age of the population was 68(11) years, with 42% males and 58% females. During follow up, 38.5% patients developed 
angiographically significant CAD (15% single vessel disease; 18% multivessel disease). Twenty % (N=17) patients underwent 
percutaneous and 13% (N=11) surgical revascularization. There was no difference in baseline demographic features and traditional risk 
factors (diabetes, hypertension, smoking, GFR, dyslipidemia) and medical therapy between those with and without CAD. Patients who 
developed CAD had significantly higher burden of inflammatory markers (CRP) and RA specific markers (RF and Anti CCP Ab) compared 
to those without CAD (all P<0.05).
Conclusion:  Traditional risk factors are limited in their predictive accuracy for CAD in patients with RA. CRP, RF and Anti CCP antibodies 
appear useful biomarkers for refining CAD risk stratification in patients with RA.
